Get started
Author

Hany A.M. El-Sherief

Observed names: El-Sherief, Hany A. M., Hany A. El-Sherief, Hany A. M. El-Sherief, Hany A. M. Elsherief, Hany A. M. El‐Sherief, Hany El-Sherief, Hany ElSherief
Institution: Deraya University
ORCID: 0000-0002-4499-1964
Observed ORCID: 0000-0002-4499-1964
OpenAlex ID: A5010365842
Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors
2018 · Hany A.M. El-Sherief, Bahaa G.M. Youssif, et al. · European Journal of Medicinal Chemistry · 186
Novel 1,2,4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies
2017 · Hany A.M. El-Sherief, Bahaa G.M. Youssif, et al. · Bioorganic Chemistry · 183
Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity
2020 · Hesham A.M. Gomaa, Hany A.M. El-Sherief, et al. · Bioorganic Chemistry · 50
Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities
2019 · Hany A.M. El-Sherief, Bahaa G.M. Youssif, et al. · Anti-Cancer Agents in Medicinal Chemistry · 45
Metabolomic profile, anti-trypanosomal potential and molecular docking studies of Thunbergia grandifolia
2023 · Heba A. S. El-Nashar, Ahmed M. Sayed, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 39
PDF
Design and synthesis of new coumarin–chalcone/NO hybrids of potential biological activity
2017 · Hany A. El-Sherief, Gamal El-Din A. Abuo-Rahma, et al. · Medicinal Chemistry Research · 33
Design, synthesis and molecular docking of 1,2,4-triazole schiff base hybrids as tubulin, EGFR inhibitors and apoptosis-inducers
2023 · Malik Suliman Mohamed, Nashwa A. Ibrahim, et al. · Journal of Molecular Structure · 29
Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
2024 · Ahmed M. Shawky, Faisal A. Almalki, et al. · European Journal of Medicinal Chemistry · 27
Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity
2023 · Ahmed M. Shawky, Faisal A. Almalki, et al. · European Journal of Medicinal Chemistry · 17
Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression
2022 · Esraa Magdy Abdelraouf, Raghda R.S. Hussein, et al. · Life Sciences · 14
Design, synthesis, antiproliferative activity, and molecular dynamics simulation of pyrazoline-based derivatives as dual EGFR and HER-2 inhibitors
2025 · Hani Mohamed Hafez, Basmat Amal M. Said, et al. · RSC Advances · 9
A decade's overview of 2‐aminothiophenes and their fused analogs as promising anticancer agents
2024 · Donia G. Darwish, Hany A. M. El‐Sherief, et al. · Archiv der Pharmazie · 8
Synthesis and evaluation of the antioxidant activity of 1,2,4-triazole derivatives
2018 · Hany A.M. El-Sherief, Mohamed Abdel‐Aziz, et al. · Journal of advanced Biomedical and Pharmaceutical Sciences · 4
Synthesis, antiproliferative activity, and molecular modeling of novel 4-methylcoumarin derivatives and/or nitric oxide donor hybrids
2022 · Malik Suliman Mohamed, Hany A. M. Elsherief, et al. · Molecular Diversity · 3
Phosphoinositide 3‐Kinase Inhibitors from Gladiolus Segetum Ker‐Gawl Corms Supported by Network Pharmacology
2024 · Basma Khalaf Mahmoud, Miada F. Abdelwahab, et al. · Chemistry & Biodiversity · 2
Development of a Multi-Target Pharmacophore-Based Virtual Screening Agent Against COVID-19
2024 · Nashwa Ibrahim, Ahmed Gouda, et al. · Al-Mustaqbal Journal of Pharmaceutical and Medical Sciences · 1
Synthesis of 1,2,4-triazole derivatives and evaluation of their antioxidant activity
2018 · Mohamed Osman, Hany ElSherief, et al. · Journal of advanced Biomedical and Pharmaceutical Sciences · 1
Works count: 18
Citation count: 651
H-index: 10
I10-index: 10
Year
Topic
Type